Product details:
| ISBN13: | 9780443316784 |
| ISBN10: | 0443316783 |
| Binding: | Hardback |
| No. of pages: | pages |
| Size: | 228x152 mm |
| Weight: | 450 g |
| Language: | English |
| 683 |
Category:
Updates on Osteoporosis Diagnosis and Therapy, An Issue of Endocrinology and Metabolism Clinics of North America
Series:
The Clinics: Internal Medicine;
Publisher: Elsevier
Date of Publication: 30 October 2024
Normal price:
Publisher's listprice:
EUR 110.99
EUR 110.99
Your price:
41 974 (39 976 HUF + 5% VAT )
discount is: 13% (approx 6 272 HUF off)
The discount is only available for 'Alert of Favourite Topics' newsletter recipients.
Click here to subscribe.
Click here to subscribe.
Availability:
printed on demand
Can't you provide more accurate information?
Long description:
In this issue of Endocrinology and Metabolism Clinics of North America, guest editor Dr. Pauline Camacho brings her considerable expertise to the topic of Updates on Osteoporosis. Top experts in the field cover the latest updates in therapies, management, and guidelines for osteoporosis, in addition to updates on FRAX tools, promising agents, and anabolic agents.
- Contains 11 relevant, practice-oriented topics including treatment of osteoporosis in chronic kidney disease population; prevention and management of post-denosumab rebound; optimal management of osteoporosis in the spinal cord population; workup and management of premenopausal osteoporosis; and more.
- Provides in-depth clinical reviews on osteoporosis, offering actionable insights for clinical practice.
- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Table of Contents:
Postmenopausal Osteoporosis: A Review of Latest Guidelines
Latest on Anabolic Agents for Osteoporosis Treatment
Treatment of Osteoporosis in Chronic Kidney Disease Population
An Update on the Fracture Risk Assessment Tool: What Have We Learned over 15D years?
Utility of Trabecular Bone Score in the Management of Patients with Osteoporosis
Prevention and Management of Denosumab Discontinuation Rebound Fractures
Optimal Management of Osteoporosis in the Spinal Cord (Injury) Population
Workup and Management of Premenopausal Osteoporosis
Diagnosis and Management of Atypical Femoral Fractures and Medication-Related Osteonecrosis of the Jaw in Patients with Osteoporosis
Latest on Anabolic Agents for Osteoporosis Treatment
Treatment of Osteoporosis in Chronic Kidney Disease Population
An Update on the Fracture Risk Assessment Tool: What Have We Learned over 15D years?
Utility of Trabecular Bone Score in the Management of Patients with Osteoporosis
Prevention and Management of Denosumab Discontinuation Rebound Fractures
Optimal Management of Osteoporosis in the Spinal Cord (Injury) Population
Workup and Management of Premenopausal Osteoporosis
Diagnosis and Management of Atypical Femoral Fractures and Medication-Related Osteonecrosis of the Jaw in Patients with Osteoporosis
